{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:27:09Z","timestamp":1768681629457,"version":"3.49.0"},"reference-count":25,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011051","name":"Council on grants of the President of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2020-192"],"award-info":[{"award-number":["075-15-2020-192"]}],"id":[{"id":"10.13039\/501100011051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Diabetes mellitus type 1 and 2 is associated with cognitive impairment. Previous studies have reported a relationship between changes in cerebral metabolite levels and the variability of glycemia. However, the specific risk factors that affect the metabolic changes associated with type 1 and type 2 diabetes in cognitive dysfunction remain uncertain. The aim of the study was to evaluate the specificity of hippocampal spectroscopy in type 1 and type 2 diabetes and cognitive dysfunction. Materials and methods: 65 patients with type 1 diabetes with cognitive deficits and 20 patients without, 75 patients with type 2 diabetes with cognitive deficits and 20 patients without have participated in the study. The general clinical analysis and evaluation of risk factors of cognitive impairment were carried out. Neuropsychological testing included the Montreal Scale of Cognitive Dysfunction Assessment (MoCA test). Magnetic resonance spectroscopy (MRS) was performed in the hippocampal area, with the assessment of N-acetylaspartate (NAA), choline (Cho), creatine (Cr), and phosphocreatine (PCr) levels. Statistical processing was performed using the commercially available IBM SPSS software. Results: Changes in the content of NAA, choline Cho, phosphocreatine Cr2 and their ratios were observed in type 1 diabetes. More pronounced changes in hippocampal metabolism were observed in type 2 diabetes for all of the studied metabolites. Primary risk factors of neurometabolic changes in patients with type 1 diabetes were episodes of severe hypoglycemia in the history of the disease, diabetic ketoacidosis (DKA), chronic hyperglycemia, and increased body mass index (BMI). In type 2 diabetes, arterial hypertension (AH), BMI, and patient\u2019s age are of greater importance, while the level of glycated hemoglobin (HbA1c), duration of the disease, level of education and insulin therapy are of lesser importance. Conclusion: Patients with diabetes have altered hippocampal metabolism, which may serve as an early predictive marker. The main modifiable factors have been identified, correction of which may slow down the progression of cognitive dysfunction.<\/jats:p>","DOI":"10.3390\/jpm11020148","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T09:06:10Z","timestamp":1613725570000},"page":"148","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Prospective Study: Highlights of Hippocampal Spectroscopy in Cognitive Impairment in Patients with Type 1 and Type 2 Diabetes"],"prefix":"10.3390","volume":"11","author":[{"given":"Julia","family":"Samoilova","sequence":"first","affiliation":[{"name":"Medical Faculty, Siberian State Medical University, 634050 Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9966-6686","authenticated-orcid":false,"given":"Mariia","family":"Matveeva","sequence":"additional","affiliation":[{"name":"Medical Faculty, Siberian State Medical University, 634050 Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Tonkih","sequence":"additional","affiliation":[{"name":"Medical Faculty, Siberian State Medical University, 634050 Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Kudlau","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Federal Medical and Biological Agency of Russia, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oxana","family":"Oleynik","sequence":"additional","affiliation":[{"name":"Medical Faculty, Siberian State Medical University, 634050 Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9612-8815","authenticated-orcid":false,"given":"Aleksandr","family":"Kanev","sequence":"additional","affiliation":[{"name":"Medical Faculty, Siberian State Medical University, 634050 Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrn4019","article-title":"Hippocampal insulin resistance and cognitive dysfunction","volume":"16","author":"Biessels","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_2","first-page":"1118","article-title":"Effect of Type 2 Diabetes Mellitus on Brain Metabolites by Using Proton Magnetic Resonance Spectroscopy\u2014A Systematic Review","volume":"5","author":"Santhakumari","year":"2014","journal-title":"Int. J. Pharma Bio Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24966\/DMD-201X\/100011","article-title":"Metabolism in the Diabetic Brain: Neurochemical Profiling by 1H Magnetic Resonance Spectroscopy","volume":"3","author":"Duarte","year":"2016","journal-title":"DMD"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s11064-015-1772-1","article-title":"In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders","volume":"40","author":"Sherry","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.neurobiolaging.2014.01.135","article-title":"Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by 1H magnetic resonance spectroscopy","volume":"35","author":"Duarte","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.55.2.210","article-title":"Regional metabolic patterns in mild cognitive impairment and Alzheimer\u2019s disease. A 1H MRS study","volume":"55","author":"Kantarci","year":"2000","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2217\/fnl.14.13","article-title":"What have novel imaging techniques revealed about metabolism in the aging brain?","volume":"9","author":"Lin","year":"2014","journal-title":"Future Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17116\/jnevro202012003119","article-title":"A prognostic model of cognitive impairment in patients with type 1 diabetes mellitus","volume":"120","author":"Samoilova","year":"2020","journal-title":"Zhurnal Nevrol. Psikhiatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jgs.16267","article-title":"MoCA Test Mandatory Training and Certification: What Is the Purpose?","volume":"68","author":"Nasreddine","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.184.1.1319074","article-title":"Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: Detection with proton MR spectroscopy","volume":"184","author":"Kreis","year":"1992","journal-title":"Radiology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1088\/1742-6596\/803\/1\/012046","article-title":"Bionic models for identification of biological systems","volume":"803","author":"Gerget","year":"2017","journal-title":"J. Phys. Conf. Ser."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: Overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.mri.2014.04.020","article-title":"Brain metabolite alterations demonstrated by proton magnetic resonance spectroscopy in diabetic patients with retinopathy","volume":"32","author":"Tong","year":"2014","journal-title":"Magn. Reson. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JAD-160111","article-title":"Disrupted White Matter Network and Cognitive Decline in Type 2 Diabetes Patients","volume":"53","author":"Zhang","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.20538\/1682-0363-2020-2-189-194","article-title":"Neuroimaging methods for assessing the brain in diabetes mellitus (literature review)","volume":"19","author":"Matveeva","year":"2020","journal-title":"Bull. Sib. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fneur.2019.01068","article-title":"Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients with T2DM by 1H-MRS","volume":"10","author":"Lu","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_17","first-page":"45","article-title":"Clinical analysis of hydrogen proton spectroscopy in hippocampus of type 2 diabetic patients","volume":"32","author":"Ma","year":"2010","journal-title":"Modern J. Integr. Tradit. Chin. Western Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/nbm.896","article-title":"Metabolic profile of the hippocampus of Zucker Diabetic Fatty rats assessed by in vivo 1H magnetic resonancespectroscopy","volume":"17","author":"Janssen","year":"2004","journal-title":"NMR Biomed."},{"key":"ref_19","first-page":"1738","article-title":"Region-Specific Cerebral Metabolic Alterations in Streptozotocin-Induced Type 1 Diabetic Rats: An in vivo Proton Magnetic Resonance Spectroscopy Study","volume":"35","author":"Zhang","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2337\/db16-0068","article-title":"Brain Lactate Concentration Falls in Response to Hypoglycemia in Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycemia","volume":"65","author":"Wiegers","year":"2016","journal-title":"Diabetes"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bejide, M., Contreras, P., Homm, P., Duran, B., Garc\u00eda-Merino, J.A., Rosenkranz, A., DeNardin, J.C., Del R\u00edo, R., and Hevia, S.A. (2020). Nickel Nanopillar Arrays Electrodeposited on Silicon Substrates Using Porous Alumina Templates. Molecules, 25.","DOI":"10.3390\/molecules25225377"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(08)70021-8","article-title":"Cognition and diabetes: A lifespan perspective","volume":"7","author":"Biessels","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jdiacomp.2018.12.016","article-title":"Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes","volume":"33","author":"Hansen","year":"2019","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhao, X., Han, Q., Gang, X., and Wang, G. (2018). Altered brain metabolites in patients with diabetes mellitus and related complications\u2014Evidence from 1H MRS study. Biosci. Rep., 38.","DOI":"10.1042\/BSR20180660"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/PSY.0000000000000207","article-title":"The Impact of Diabetes on Cerebral Structure and Function","volume":"77","author":"Seaquist","year":"2015","journal-title":"Psychosom. Med."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/2\/148\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:26:11Z","timestamp":1760160371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/2\/148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["jpm11020148"],"URL":"https:\/\/doi.org\/10.3390\/jpm11020148","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]}}}